Edition:
United States

First Republic News Headlines

BRIEF-4Sc: FDA Accepts IND Application For MERKLIN 2 Study

* INVESTIGATIONAL NEW DRUG (IND) APPLICATION FOR DOMATINOSTAT IN COMBINATION WITH AVELUMAB (BAVENCIO(R)) HAS BEEN ACCEPTED BY U.S. FOOD AND DRUG ADMINISTRATION (FDA) Source text for Eikon: Further company coverage: (Gdansk Newsroom)

Politics Video

Politics News